Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
FQuintero (talk | contribs)
editor
355 edits
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(109 intermediate revisions by 6 users not shown)
Line 3: Line 3:
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''!!'''Associate Editor'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
!Author Content (Pending or Complete)
!'''Date Assigned to Author'''
!Editor Reviewed (Date)
!'''Target Completion Date'''
!Notes
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|complete
|
|Fabiola Quintero-Rivera (FQR)
|Fabiola Quintero-Rivera (FQR)
|PENDING
|
|
|
|
Line 16: Line 22:
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
| ||FQR
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|
|FQR
|
|
|
|
Line 29: Line 42:
|    Polycythaemia Vera  (PV)||Disease
|    Polycythaemia Vera  (PV)||Disease
|Gokce A. Toruner
|Gokce A. Toruner
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
Line 36: Line 52:
|    Primary Myelofibrosis  (PMF)||Disease
|    Primary Myelofibrosis  (PMF)||Disease
|T. Niroshi  Senaratne
|T. Niroshi  Senaratne
|
|
|complete
|
|FQR
|FQR
|PENDING
|8/4/2020 before submission
|
|
|
|-
|-
|    Essential  Thrombocythaemia (ET)||Disease
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
|
|
|complete/pending faculty review
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|Mark Evans (trainee), Fabiola Quintero-Rivera
|(trainee), Daynna J.Wolff
|FQR
|
|
|
|
|pending faculty review
|
|
|-
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Mark Evans (trainee)+ Fabiola Quintero-Rivera
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Thomas Lee
|8/17/2020
|9/7/2020
|complete
|
|
|FQR
|
|
|-
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
|
|
|complete
| ||FQR
|
|
|
|
|-
|-
|    Cutaneous  Mastocytosis||Disease
|    Cutaneous  Mastocytosis||Disease
|Thuy Phung
|Thuy Phung/Shuo-Shawn Liu
|
|
|complete/pending adding content online as of 2/4/21
|
|FQR
|FQR
|PENDING
|
|
|
|
Line 76: Line 110:
|    Systemic Mastocytosis||Disease
|    Systemic Mastocytosis||Disease
|Shashi Shetty
|Shashi Shetty
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Mast Cell Sarcoma||Disease
|    Mast Cell Sarcoma||Disease
|Thuy Phung
|Thuy Phung +Jordan Lowery
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|FQR
|PENDING
|
|
|
|
|-
|complete
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden
|
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|FQR
|Complete
|
|
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|FQR
|Complete
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|
|
|Complete
|
|FQR
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|
|
|Complete
|
|FQR
|FQR
|Complete
|
|
|
|
Line 121: Line 176:
|Disease
|Disease
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|Complete
|
|FQR
|FQR
|Complete
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
Line 129: Line 187:
|Disease
|Disease
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|FQR
|
|PENDING
|
|Complete
|
|FQR
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|
|
|Complete
|
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|
|9/1/20
|PENDING
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|FQR
|PENDING
|
|
|
|
|-
|complete
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''|| ||FQR
|
|
|FQR
|
|
|
|
|-
|-
|    Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du+Teresa Smolarek
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|FQR
|PENDING
|
|
|9/1/20
|pending
|
|
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu+Teresa Smolarek
|FQR
|FQR
|COMPLETE
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu+Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|FQR
|COMPLETE
|
|
|9/1/20
|PENDING
|
|
|-
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du+Teresa Smolarek
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du+Teresa Smolarek
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|FQR
|PENDING
|
|
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu+Teresa Smolarek
|FQR
|Complete
|Complete
|
|
|
|-
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu+Teresa Smolarek
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Refractory Cytopenia of Childhood||Disease||Xiaoli Du+Teresa Smolarek
|    Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|FQR
|PENDING
|
|
|
|
|-
|Complete
| || || ||
|
|
|FQR
|
|
|
|
|-
|-
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|Complete
|
|
|9/1/20
|PENDING
|
|
|-
|FQR
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)||JH / MS
|    Myelodysplastic Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|PENDING
|PENDING
|
|FQR
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang||JH / MS
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|PENDING
|
|
|
|Complete
|
|
|-
|FQR
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori||JH / MS
|PENDING
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ANKRD26 Mutation||Disease||Fei Yang||JH / MS
|    Myelodysplastic Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|PENDING
|
|
|
|complete
|
|
|-
|FQR
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou||JH / MS
|Complete
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline GATA2 Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)||JH / MS
|    Refractory Cytopenia of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|Complete
|
|
|9/1/20
|PENDING
|
|
|-
|FQR
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH / MS
| || ||
|Complete
|
|
|
|
|
|-
| ||
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty||JH / MS
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|Complete
|
|
|
|
|-
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH / MS
|Complete
|Complete
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|04/26/2021 -MS (re-review)
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH / MS
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
|Complete
|
|
|
|
|-
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH / MS
|Complete
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|Need permission for figure?  Update WHO?
|-
|-
|    Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH / MS
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
|Complete
|
|
|
|PENDING
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)||JH / MS
|    Myeloid Neoplasms with Germline DDX41 Mutation||Disease||Fei Yang
|Complete
|
|
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)||JH / MS
|Complete
|Complete
| ||JH / MS
|03/01/2021-MS
|
|
|Add WHO reference
|-
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)||JH / MS
|    Myeloid Neoplasms with Germline RUNX1 Mutation||Disease||Malini Sathanoori
|Complete
|
|
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)||JH / MS
|Complete
|Complete
|02/03/2021||JH / MS
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH / MS
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
|Complete
|
|
|
|
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)||JH / MS
|Complete
|Complete
| ||JH / MS
|03/02/2021-MS
|
|
|Check reference format
|-
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal||JH / MS
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
|Complete
|
|
|
|
|-
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH / MS
|Complete
|Complete
|
| ||JH / MS
|03/02/2021-MS (re-review)
|
|
|-
|-
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge||JH / MS
|    Myeloid Neoplasms with Germline GATA2 Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|Complete
|
|
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Maturation||Disease||Jennelle Hodge||JH / MS
|Complete
|Complete
|
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|
|-
|-
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH / MS
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|Complete
|
|
|
|
|-
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH / MS
|Complete
|Complete
|
|
|JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra||JH / MS
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
|Complete
|
|
|
|
|-
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH / MS
|Complete
|Complete
|
| ||JH / MS
|04/26/2021-MS (re-review)
|
|
|-
|-
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH / MS
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|Complete
|
|
|
|
|-
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)||JH / MS
|Complete
|Complete
|
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH / MS
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
|Complete
|
|
|
|
|-
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp||JH / MS
|Complete
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|Need permission for figure?
|-
|-
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley||JH / MS
|    Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|
|
|Complete
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|
|
|
|Complete
| ||JH / MS
|02/24/2021-MS (re-review)
|
|
|-
|-
|    Myeloid Leukemia Associated with Down Syndrome||Disease||Linda Cooley||JH / MS
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|
|
|Complete
|Complete
| ||JH / MS
|
|Need permission for figure?  Update WHO?
|-
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|
|
|
|
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)||JH / MS
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH / MS
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)||JH / MS
|    Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
|Complete
| ||JH / MS
|
|
|Check reference format
|Add WHO reference
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH / MS
|    Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|
|
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH / MS
|    Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|
|
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)||JH / MS
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|Complete
|
|
|
|Check reference format
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH / MS
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease|| ||JH / MS
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|??
|
|
|
|
|Complete
| ||JH / MS
|
|Check reference format
|-
|-
|    ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease|| ||JH / MS
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|??
|
|
|
|
|-
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Kay Weng Choy + Greg Conboy (Monash Health)
|JH / MS
|Complete
|Complete
| ||JH / MS
|
|
|NON-WHO ENTITY
|-
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
|Disease
|Daynna Wolff+Jessica Snider (Path Resident)
|JH / MS
|PENDING
|
|
|NON-WHO ENTITY
|-
|-
|Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6
|    Acute Myeloid Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|Disease
|Daynna Wolff+ Paige Woodham (Path Resident)
|JH / MS
|PENDING
|
|
|NON-WHO ENTITY
|-
| || || ||
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA)
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''|| ||YA
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease|| ||YA
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
|
|
|
|
|
|Complete
|-
| ||JH / MS
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|YA
|PENDING
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease|| ||YA
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
 
|
Lisa Smith + Yassmine Akkari
|
|YA
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|YA
|
|
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease|| ||YA
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
|
|
|
|
|Complete
| ||JH / MS
|
|
|Need permission for figure?
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease|| ||YA
|    Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease||Linda Cooley
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|Disease
|
|Helene Bruyere
|
|YA
|Complete
|PENDING
| ||JH / MS
|
|
|NON-WHO ENTITY
|Check reference format
|-
|-
| || || ||
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|SP
|PENDING
|
|
|
|
|-
|Complete
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
| ||JH / MS
|SP
|PENDING
|
|
|
|
|-
|-
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|SP
|PENDING
|
|
|
|
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|SP
|Complete
|Complete
| ||JH / MS
|
|
|
|Malini to review
|-
|-
|Hairy Cell Leukemia||Disease||Snehal Patel
|    Mixed-Phenotype Acute Leukemia, Not  Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
|SP
|
|Complete
|
|
|Malini to review
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|SP
|PENDING
|PENDING
| ||JH / MS
|
|
|
|Malini to review
|-
|-
|    Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|    Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
|SP
|PENDING
|
|
|Malini to review
|-
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|SP
|Complete
|
|
|Malini to review
|-
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
|SP
|PENDING
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
|   Waldenstrom Macroglobulinemia||Disease||Honey Reddi
|Acute Myeloid Leukemia (AML) with Mutated FLT3
|SP
|Disease
|PENDING
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
|-
|Complete
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|-
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
|Disease
|Daynna Wolff+Jessica Snider (Path Resident)
|
|
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||SP
|
|
|PENDING
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|-
|-
|    Mu Heavy Chain Disease||Disease|| ||SP
|Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6
|Disease
|Daynna Wolff+ Paige Woodham (Path Resident)
|
|
|
|
|PENDING
|
|JH / MS
|
|
|NON-WHO ENTITY
|-
|-
|   Gamma Heavy Chain  Disease||Disease|| ||SP
| || ||
|
|
|
|
| ||
|
|
|
|
|-
|-
|    Alpha Heavy Chain  Disease||Disease|| ||SP
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|
|-
| ||Yassmine Akkari (YA)
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|SP
|PENDING
|
|
|
|
|-
|-
|   Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||
|SP
|
|PENDING
|
|
|
|
|-
| ||YA
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|SP
|PENDING
|
|
|
|
|-
|-
|    Plasma Cell Myeloma Variants||Disease||Zhenya Tang
|    B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
|SP
|PENDING
|
|
|
|
|-
|    Plasmacytoma||Disease||Zhenya Tang
|SP
|PENDING
|PENDING
| ||YA
|
|
|
|
|-
|-
|'''''    Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|
|
|
|
|PENDING
|
|
|-
|YA
|           Primary  Amyloidosis||Disease|| ||SP
|
|
|
|
|
|-
|-
|           Light Chain and Heavy Chain Deposition Disease||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|         POEMS Syndrome||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
 
Lisa Smith + Yassmine Akkari
|
|
|
|Complete
|
|YA
|
|
|
|
|-
|-
|         TEMPI Syndrome||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
|    B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|SP
|
|
|PENDING
|PENDING
| ||YA
|
|
|
|
|-
|-
|Nodal Marginal Zone Lymphoma||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|
|
|Complete
|
|
|YA
|
|
|
|
|-
|-
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|    B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease||Holli Drendel
|SP
|
|
|PENDING
|PENDING
| ||YA
|
|
|
|
|-
|-
|Follicular Lymphoma||Disease||Ruthann Pfau
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
|SP
|PENDING
|
|
|
|
|-
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|SP
|PENDING
|PENDING
| ||YA
|
|
|
|
|-
|-
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|SP
|Disease
|PENDING
|Diana Rush
|
|
|
|
|-
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
|SP
|PENDING
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|SP
|Disease
|PENDING
|Celeste Eno
|
|
|
|
|-
|PENDING
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP
|
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|
|Disease
|Marilena Melas
|
|
|
|
|-
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|SP
|PENDING
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|SP
|Disease
|PENDING
|Chenkai Ma
|
|
|
|
|-
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
|SP
|PENDING
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
| || || ||
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease|| ||Greg Corboy (GC)
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Alaa Koleilat
|
|
|
|
|PENDING
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease|| ||GC
| || ||
|
|
|
|
|
|-
|EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC
|
|
| ||
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease|| ||GC
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease|| ||GC
|
|
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|Lymphomatoid Granulomatosis||Disease|| ||GC
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|
|
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC
|
|
|SP
|
|
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease|| ||GC
|       Monoclonal B-cell Lymphocytosis||Disease||
|
|
|
|
|
|
|-
|ALK-Positive Large B-cell Lymphoma||Disease|| ||GC
|
|
|SP
|
|
|
|
|-
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera||GC
|B-cell Prolymphocytic Leukemia||Disease||
|Complete
|
|
|
|
|
|-
|Primary Effusion Lymphoma||Disease|| ||GC
|
|
|SP
|
|
|
|
|-
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|
|SP
|
|
|
|
|-
|-
|   Multicentric Castleman  Disease||Disease|| ||GC
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|
|
|Complete
|
|
|-
|SP
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease|| ||GC
|
|
|
|
|
|-
|-
|Burkitt Lymphoma||Disease|| ||GC
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
|-
|SP
|Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC
|
|
|
|
|
|-
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
|-
|SP
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC
|
|
|
|
|
|-
|-
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|
|
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC
|
|
|SP
|
|
|
|
|-
|-
| || || ||
|   Waldenstrom  Macroglobulinemia||Disease||
|
|
|
|
|
|
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
|
|
|SP
|
|
|
|
|-
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don||SP
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|PENDING
|
|
|
|
|-
|
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don||SP
| ||SP
|PENDING
|
|
|
|
|-
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don||SP
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|PENDING
|
|
|
|
|-
|Aggressive NK-cell Leukemia||Disease|| ||SP
|
|
| ||SP
|
|
|
|
|-
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood'''''||'''''Overview'''''|| ||SP
|    Mu Heavy Chain Disease||Disease||
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|  Systemic EBV-Positive T-cell Lymphoma of Childhood||Disease|| ||SP
|   Gamma Heavy Chain Disease||Disease||Manisha Sutariya
|
|
|
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|   Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form||Disease|| ||SP
|    Alpha Heavy Chain Disease||Disease||
|
|
|
|
|
|-
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease|| ||SP
|
|
| ||SP
|
|
|
|
|-
|-
|    Severe Mosquito Bite  Allergy||Disease|| ||SP
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|
|
|PENDING
|
|
|-
|SP
|Adult T-cell Leukemia/Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| ||SP
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|
|
|PENDING
|
|
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|SP
|SP
|PENDING
|
|
|
|
|-
|-
|      Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|SP
|
|
|PENDING
|PENDING
|
|
|
|-
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|SP
|SP
|PENDING
|
|
|
|
|-
|-
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|
|
|PENDING
|
|SP
|SP
|PENDING
|
|
|
|
|-
|-
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|    Plasmacytoma||Disease||Zhenya Tang
|SP
|PENDING
|
|
|
|
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don||SP
|PENDING
|PENDING
|
|SP
|
|
|
|
|-
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| ||SP
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
|
|
|
|-
| ||SP
|Mycosis Fungoides||Disease|| ||SP
|
|
|
|
|
|-
|-
|Sézary Syndrome||Disease|| ||SP
|           Primary  Amyloidosis||Disease||
|
|
|
|
|
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''|| ||SP
|
|
| ||SP
|
|
|
|
|-
|-
|    Lymphomatoid Papulosis||Disease|| ||SP
|           Light Chain and Heavy Chain Deposition Disease||Disease||
|
|
|
|
|
|-
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease|| ||SP
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| ||SP
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|
|
|
|
|
|-
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease|| ||SP
|
|
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| ||SP
|         POEMS Syndrome||Disease||
|
|
|
|
|
|-
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease|| ||SP
|
|
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| ||SP
|         TEMPI Syndrome||Disease||
|
|
|
|
|
|
|-
| ||SP
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||SP
|
|
|
|
|
|-
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''|| ||SP
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|3/9/21
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|SP
|
|
|
|Complete
|5/28/2021||SP
|
|
|
|
|-
|-
|    Follicular T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|Complete
|11/11/2020
|SP
|SP
|
|
|
|
|
|-
|-
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease|| ||SP
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|SP
|SP
|PENDING
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|SP
|
|
|PENDING
|PENDING
|
|
|
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|SP
|SP
|PENDING
|
|
|
|
|-
|-
| || || ||
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
|-
|SP
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| ||Associate Editor??
|
|
|
|
|
|-
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| ||
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
|-
|SP
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| ||
|
|
|
|
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease|| ||
|
|
|Complete
|8/16/2020
|SP
|
|
|
|
|-
|-
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease|| ||
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|
|
|9/30/20
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease|| ||
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease|| ||
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|
|8/15/20
|PENDING
|
|SP
|
|
|
|
|-
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||
|
|
|
|
|
|
|-
|Lymphomas Associated with HIV Infection||Disease|| ||
|
|
|SP
|
|
|
|
|-
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
|    In Situ Mantle Cell  Neoplasia||Disease||
|
|
|
|
|
|
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
|
|
|SP
|
|
|
|
|-
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
| || ||
 
Fabiola Quintero-Rivera
|
|PENDING
|
|
|
|
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| ||
|
|
| ||
|
|
|
|
|-
|-
|          Monomorphic  B-cell PTLD||Disease|| ||
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|
|
|
|
|PENDING
|
|
|-
|Greg Corboy (GC)
|          Monomorphic  T/NK-cell PTLD||Disease|| ||
|
|
|
|
|
|-
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| ||
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|-
| ||GC
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease|| ||
|
|
|
|
|
|-
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| ||
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
|
|
|
|-
| ||GC
|Histiocytic Sarcoma||Disease|| ||
|
|
|
|
|
|-
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| ||
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|
|
|
|
|
|
|-
| ||GC
|   Langerhans Cell  Histiocytosis||Disease|| ||
|
|
|
|
|
|-
|-
|   Langerhans Cell Sarcoma||Disease|| ||
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|-
|Indeterminate Dendritic Cell Tumour||Disease|| ||
|
|
| ||GC
|
|
|
|
|-
|-
|Interdigitating Dendritic Cell Sarcoma||Disease|| ||
|EBV-Positive Mucocutaneous Ulcer||Disease||
|
|
|
|
|
|-
|Follicular Dendritic Cell Sarcoma||Disease|| ||
|
|
| ||GC
|
|
|
|
|-
|-
|    Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| ||
|Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation||Disease||
|
|
|
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease|| ||
|
|
| ||GC
|
|
|
|
|-
|-
|Disseminated Juvenile Xanthogranuloma||Disease|| ||
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|-
| ||GC
|Erdheim-Chester Disease||Disease|| ||
|
|
|
|
|
|-
|-
| || || ||
|Lymphomatoid Granulomatosis||Disease||
|
|
|
|
|
|-
| || || ||
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|-
| ||GC
| || || ||
|
|
|
|
|
|-
|-
| || || ||
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
|
|-
| || || ||
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|ALK-Positive Large B-cell Lymphoma||Disease||
|
|
|
|
|
|-
| || || ||
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|
|Complete
| ||GC
|
|
|
|
|-
|-
| || || ||
|Primary Effusion Lymphoma||Disease||
|
|
|
|
|
|-
| || || ||
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|
|-
| ||GC
| || || ||
|
|
|
|
|
|-
|-
| || || ||
|   Multicentric Castleman  Disease||Disease||
|
|
|
|
|
|-
| || || ||
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|
|-
| ||GC
| || || ||
|
|
|
|
|
|-
|-
| || || ||
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
|-
| ||GC
| || || ||
|
|
|
|
|
|-
|-
| || || ||
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|
|
|PENDING
| ||GC
|
|
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Associate Editor'''
!Author Content
(Pending or Complete)
!Editor Reviewed (Date)
!Notes
|-
|-
|BCR
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|ABL1
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|RUNX1
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|RUNX1T1
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|MYH11
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|FLT3
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|NPM1
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|TP53
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|DNMT3A
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|CEBPA
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|IDH1
|Aggressive NK-cell Leukemia||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|IDH2
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|PML
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|RARA
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|ETV6
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|KIT
|    Severe Mosquito Bite  Allergy||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|CBFB
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|GATA2
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|PTEN
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|MLTT3
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|
|Complete
|1/21/2021
|SP
|
|
|
|
|-
|-
|MECOM
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|FGFR1(FLT2)
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|KMT2A
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|DEK
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|
|
|
|Complete
|1/21/2021
|SP
|
|
|
|
|-
|-
|NUP214
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|RBM15
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|MKL1
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|DDX41
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|ANKRD26
|    Lymphomatoid  Papulosis||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|CUX1
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|TET2
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|EZH2
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|FOXP1
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|MYC
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|JAK2
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|WT1
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|CBL
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|NF1
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|SUZ12
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|ERG
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|EST2
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|RPS14
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||Greg Corboy (GC)
|
|
|
|
|-
|-
|RB1
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|MPL
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|CHGA
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|CDH1
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|SRSF2
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|DNMT1
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
| ||GC
|
|
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
| ||GC
|
|
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 
Fabiola Quintero-Rivera
|
|
|PENDING
|
|GC
|
|
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|          Monomorphic  B-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|-
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
| ||GC
|
|
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|Histiocytic Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|   Langerhans Cell  Histiocytosis||Disease||
|
|
|
| ||GC
|
|
|-
|   Langerhans Cell  Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
| ||GC
|
|
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||GC
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||GC
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
| ||GC
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|BCR
|Brian Davis
|
|
|Complete
|8/10/18
|
|
|
|-
|ABL1
|Brian Davis
|
|
|Complete
|4/16/19
|
|
|
|-
|RUNX1
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|RUNX1T1
|Brian Davis
|
|
|Complete
|5/23/19
|
|
|
|-
|MYH11
|Brian Davis
|
|
|Complete
|8/6/18
|
|
|
|-
|FLT3
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|NPM1
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|TP53
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|DNMT3A
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|CEBPA
|Gordana
|
|
|Complete
|
|
|
|
|-
|IDH1
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|IDH2
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|PML
|Brian Davis
|
|
|Complete
|12/5/18
|
|
|
|-
|RARA
|Brian Davis
|
|
|Complete
|8/3/18
|
|
|
|-
|ETV6
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|KIT
|Brian Davis
|
|
|Complete
|10/1/18
|
|
|
|-
|CBFB
|Brian Davis
|
|
|Complete
|8/2/18
|
|
|
|-
|GATA2
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|PTEN
|Beth Pitel
|
|
|Pending
|
|
|
|
|-
|MLTT3
|
|
|
|
|
|
|
|
|-
|MECOM
|Brian Davis
|
|
|Pending
|
|
|
|
|-
|FGFR1(FLT2)
|Brian Davis
|
|
|Pending
|
|
|
|
|-
|KMT2A
|
|
|
|
|
|
|
|
|-
|DEK
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|-
|NUP214
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|-
|RBM15
|
|
|
|
|
|
|
|
|-
|MKL1
|
|
|
|
|
|
|
|
|-
|DDX41
|Ying Zou
|8/7/20
|
|Pending
|
|
|
|
|-
|ANKRD26
|
|
|
|
|
|
|
|
|-
|CUX1
|
|
|
|
|
|
|
|
|-
|TET2
|
|
|
|
|
|
|
|
|-
|EZH2
|
|
|
|
|
|
|
|
|-
|FOXP1
|
|
|
|
|
|
|
|
|-
|MYC
|
|
|
|
|
|
|
|
|-
|JAK2
|
|
|
|
|
|
|
|
|-
|WT1
|DONE
|
|
|DONE
|
|
|
|
|-
|CBL
|
|
|
|
|
|
|
|
|-
|NF1
|
|
|
|
|
|
|
|
|-
|SUZ12
|
|
|
|
|
|
|
|
|-
|ERG
|
|
|
|
|
|
|
|
|-
|EST2
|
|
|
|
|
|
|
|
|-
|RPS14
|
|
|
|
|
|
|
|
|-
|RB1
|
|
|
|
|
|
|
|
|-
|MPL
|
|
|
|
|
|
|
|
|-
|CHGA
|
|
|
|
|
|
|
|
|-
|CDH1
|
|
|
|
|
|
|
|
|-
|SRSF2
|
|
|
|
|
|
|
|
|-
|DNMT1
|
|
|
|
|
|
|
|
|-
|PRDX2
|
|
|
|
|
|
|
|
|-
|ASXL1
|DONE
|
|
|DONE
|
|
|
|
|-
|MN1
|
|
|
|
|
|
|
|
|-
|SF3A1
|
|
|
|
|
|
|
|
|-
|EP300
|
|
|
|
|
|
|
|
|-
|JARID2
|
|
|
|
|
|
|-
|PRDX2
|
|
|
|
Line 1,733: Line 2,756:
|
|
|-
|-
|ASXL1
|BRCA1
|
|
|
|
|
|-
|MN1
|
|
|
|
|
|
|
|
|-
|SF3A1
|
|
|
|
Line 1,754: Line 2,766:
|
|
|-
|-
|EP300
|BRCA2
|
|
|
|
|
|
|
|
|-
|JARID2
|
|
|
|
Line 1,771: Line 2,779:
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,785: Line 2,789:
|
|
|
|
|
|
|
|-
|
|
|
|
Retrieved from "https://content.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"